Real Heart Total Liabilities

Latest as of June 2025: Skr13.59 Million SEK ≈ $1.46 Million USD

Real Heart total liabilities. Based on the latest financial reports, Real Heart (HEART) has total liabilities worth Skr13.59 Million SEK (≈ $1.46 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Real Heart liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Real Heart (2010–2024)

Total liabilities of Real Heart from 2010 to 2024. This chart illustrates how Real Heart's total liabilities have evolved over time, based on quarterly financial data.

Real Heart Competitors by Total Liabilities

The table below lists competitors of Real Heart ranked by their total liabilities.

Company Country Total Liabilities
Federal International Holdings Bhd
KLSE:8605
Malaysia RM79.09 Million
BIG Industries Bhd
KLSE:7005
Malaysia RM20.42 Million
Victoria Insurance Tbk PT
JK:VINS
Indonesia Rp62.26 Billion
Immuron Ltd
AU:IMC
Australia AU$2.06 Million
U-BX Technology Ltd.
NASDAQ:UBXG
USA $1.37 Million
Plascar Participações Industriais S.A
SA:PLAS3
Brazil R$1.38 Billion
LDT Inc
KQ:096870
Korea ₩2.45 Billion
Zyrexindo Mandiri Buana PT Tbk
JK:ZYRX
Indonesia Rp496.67 Billion

Liability Composition Analysis (2010–2024)

This chart breaks down Real Heart's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Real Heart assets under control.

Liquidity & Leverage Metrics

Real Heart Total Liabilities Ratios Explained

Real Heart total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.96 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Real Heart's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Real Heart (2010–2024)

The table below shows the annual total liabilities of Real Heart from 2010 to 2024.

Year Total Liabilities Change
2024-12-31 Skr15.94 Million
≈ $1.72 Million
-22.62%
2023-12-31 Skr20.60 Million
≈ $2.22 Million
-7.08%
2022-12-31 Skr22.17 Million
≈ $2.39 Million
+239.78%
2021-12-31 Skr6.53 Million
≈ $702.20K
+2.75%
2020-12-31 Skr6.35 Million
≈ $683.39K
-16.57%
2019-12-31 Skr7.61 Million
≈ $819.12K
-6.31%
2018-12-31 Skr8.12 Million
≈ $874.25K
+26.15%
2017-12-31 Skr6.44 Million
≈ $693.01K
+60.72%
2016-12-31 Skr4.01 Million
≈ $431.18K
+534.12%
2015-12-31 Skr631.85K
≈ $68.00K
-26.28%
2014-12-31 Skr857.12K
≈ $92.24K
+1.78%
2013-12-31 Skr842.11K
≈ $90.62K
+91.93%
2012-12-31 Skr438.75K
≈ $47.22K
+613.58%
2011-12-31 Skr61.49K
≈ $6.62K
-15.36%
2010-12-31 Skr72.65K
≈ $7.82K
--

About Real Heart

ST:HEART Sweden Medical Devices
Market Cap
$9.14 Million
Skr84.98 Million SEK
Market Cap Rank
#27152 Global
#588 in Sweden
Share Price
Skr17.00
Change (1 day)
+0.29%
52-Week Range
Skr13.15 - Skr23.50
All Time High
Skr1625.78
About

Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis to fix the sternum after open-chest surgery. The company was founded in 1999 and is bas… Read more